EPO published patent application EP3876983A1 for an immunogenic composition against avian influenza H5 subtype. The application claims priority with inventors Mundt, Cui, and Hu and is classified under A61K 39/12 and A61P 31/16. The patent designates all standard EPO contracting states including Germany, France, UK, Italy, Spain, and 39 others.

Patent publications do not impose compliance requirements on industry. Companies developing competing avian influenza vaccines should review the patent claims to assess potential freedom-to-operate concerns. Parties may access the full application via the EPO register using application number EP3876983.